The production of MG (methylglyoxal) in bacterial cells must be maintained in balance with the capacity for detoxification and protection against this electrophile. Excessive production of MG leads to cell death. Survival of exposure to MG is best understood in the Gram-negative bacteria. The major mechanism of protection is the spontaneous reaction of MG with GSH to form hemithiolacetal, followed by detoxification by the glyoxalase system leading to the production of d-lactate. The KefB and KefC glutathione-gated K + efflux systems are integrated with the activity of the glyoxalase system to regulate the cytoplasmic pH in response to exposure to electrophiles. Bacteria only produce MG when an imbalance occurs in metabolism. Operation of the MG bypass enables cells to adapt, such that balance is restored to metabolism. Excessive production of MG is an adaptive ploy, which, if it fails, has fatal consequences. On this basis one might define MG-induced loss of life as 'death by misadventure' rather than suicide!
Introduction
After decades of neglect by bacterial physiologists, the last 10 years has seen a resurgence of interest in MG (methylglyoxal), culminating in the crystal structures of important enzymes [1, 2] , the creation of null mutants in key enzymes and transport systems [3] [4] [5] and detailed analysis of the production and consumption of this toxic electrophile. We are now in a position where many central aspects of the role and metabolism of MG are understood. In addition, recent in vivo analyses of gene expression are beginning to suggest a key role for this electrophile in the physiology of intracellular pathogens. Bacteria (Salmonella and Brucella) that have been engulfed by macrophages express GlxI (glyoxalase I) at increased levels, and in one case KefB expression is elevated relative to that in cells grown in broth [6, 7] . There can be genuine optimism that understanding the metabolism of electrophiles offers a hope for novel strategies for prevention of, or intervention in, microbial infections. In this brief review the current understanding of the relationships between micro-organisms and MG will be explored.
MG production
In bacteria, most of the evidence favours the production of MG from dihydroxyacetone phosphate via the enzyme MGS (MG synthase), encoded in Escherichia coli by the mgsA gene [4] . Alternative routes also exist in higher organisms, but are poorly documented in bacteria. MGS was first purified by Hopper and Cooper [8] and predicted to be a homotetramer of 16.9 kDa subunits. The enzyme was shown to be homotropically activated by the substrate, dihydroxyacetone phosphate, and allosterically inhibited by its product, phosphate [8] . Even in E. coli cells that overexpress the enzyme ∼1000-fold, MG accumulation is not detectable, indicating that production of MG is well below the rate at which it can be detoxified [4] . The structural gene was subsequently cloned from E. coli after partial purification and N-terminal sequencing of candidate proteins, and this led to the creation of an mgsA null mutant and also of overexpressing strains [4] . In parallel, the gene was cloned, and the protein expressed and crystallized [2] , which has enabled detailed analysis of the mechanism of the enzyme. In physiological terms the enzyme appears to be most important when there is an imbalance between the rate of carbon acquisition and the capacity of the lower segment of glycolysis. These are the conditions most associated with MG production. Failure to synthesize MG, due to an mgsA null mutation, leads to a more rapid onset of growth inhibition when cells are exposed to xylose in the presence of cAMP, possibly due to the toxicity of the accumulated phosphorylated metabolites [4] .
The primary role of MGS is the increased turnover of phosphate in the cell. In E. coli, growth in phosphate-limited medium led to a slight accumulation of MG that could be stimulated if MGS was overexpressed, suggesting that the limitation was the specific activity of the enzyme in cells, which is normally very low. In the macrophage, there is evidence that the induction of glutathione synthase, GlxI and KefB in Salmonella is co-ordinated with the onset of expression of genes associated with phosphate limitation. No comparable data are available for Brucella, but the rise in GlxI would be consistent with increased production of MG, and, given that this is unlikely to be driven by a sudden increased availability of carbon source, phosphate limitation seems likely. No matter what the stimulus for MG production, survival requires detoxification and protection.
MG detoxification and protective mechanisms
There are three pathways for MG detoxification in the enteric bacteria [9] . Kinetically the most important enzyme pathway is the glutathione-dependent GlxI/GlxII (glyoxylase II) pathway, encoded by the gloA and gloB genes in E. coli. It is now evident that these genes are widespread in bacteria, even among bacteria not thought to synthesize GSH ( [10] ; I.R. Booth, unpublished work). Both glutathionedeficient mutants and GlxI-deficient mutants are severely impaired in MG metabolism, although both mutant classes exhibit significant detoxification capacity [5, 11] . An aldoketo reductase that has a broad substrate specificity, including a low affinity for MG, has been implicated in detoxification when overexpressed [12] . A novel glyoxalase (GlxIII), which catalyses the glutathione-independent conversion of MG into D-lactate, has been purified to homogeneity from E. coli extracts. The gene has not been identified and no mutants are known in this system [13] .
Bacterial cells have an intrinsic ability to withstand the toxic effects of MG that is influenced by the permeability of the membrane, the capacity for DNA repair and the levels of detoxification enzymes [14] . Previous work has shown that, for E. coli, a further factor is the K + concentration in the environment, since high K + concentrations (>10 mM) will inhibit the activity of the KefB and KefC efflux systems that are intrinsic components of the protection mechanism [3, 11, 15, 16] . Whether MG is added to the medium, or is generated intracellularly, does not appear to affect the intrinsic sensitivity of E. coli cells. Growth inhibition appears to set in when the MG concentration in the growth medium reaches 0.3 mM, and loss of viability becomes evident above 0.6 mM. To an extent the absolute values of these threshold concentrations depend on the density of the bacterial culture, since high cell densities possess greater detoxification capacity. Further, the nature of the growth medium also strongly influences the actual concentration of free MG [14] . Mutants that lack one of the protective components or are incubated at high external K + concentrations exhibit lower threshold MG concentrations at which growth inhibition and loss of viability become evident [5, 11] .
The mechanism by which MG exerts growth inhibition may be distinct from that causing loss of cell viability. The reaction of MG with cysteine residues in specific proteins may be sufficient to cause growth inhibition [17] . Protein and DNA synthesis have previously been identified as sensitive targets, but the precise mechanisms remain unclear [18] . MG modifies DNA and proteins, and the effects seen on macromolecular syntheses may be the result of generalized damage rather than actions on specific enzyme complexes. MG is a known mutagen, which implies that DNA damage occurs even in surviving cells [19, 20] . Fragmentation of the genome was seen in E. coli cells treated with MG, but was not the cause of cell death, since uvrA mutants exhibited the same rate of killing as the parent, but did not exhibit DNA breakdown [21] .
The principal events taking place after the cells are exposed to MG are the rapid formation of glutathione adducts in the cytoplasm. Simultaneously, MG reacts with the guanine bases in the DNA, forming N 2 -(1-carboxyethyl)-9-methylguanine, which become the substrate for DNA repair enzymes [22] . In parallel, MG reacts with thiol groups of proteins, causing inhibition of some enzyme activities [17] . Mutants lacking GlxI do not activate KefB or KefC in the presence of MG; it appears that the initial glutathione adduct, hemithiolacetal, does not elicit strong activation of the KefB K + efflux system. Only after GlxI has catalysed the formation of SLG (Slactoylglutathione) is the KefB system activated. SLG is the substrate for GlxII, which leads to the regeneration of GSH, which inhibits KefB, and the release of D-lactate from the cell. The acidification of the cytoplasm associated with KefB activation is a major mediator of protection against the electrophile [16] .
KefB and KefC are a pair of K + efflux systems that are related at the sequence level, and have similar predicted organizations in the membrane and essentially the same core mechanism of regulation [9] . Although the enteric bacteria tend to have both KefB and KefC in the wider bacterial genomes, KefB is the more frequently observed protein.
Both proteins contain ∼600 amino acids and comprise four domains: the inner membrane domain, the linker, the Ktn domain and the SM domain [23] . In addition, each system requires a specific additional protein: KefF for KefC and KefG for KefB [24] . KefF and KefG are strongly related to the quinine oxidoreductase family of proteins with which they share the same basic fold. Both KefB-KefG and KefCKefF complexes mediate K + efflux that is accompanied by Na + and H + influx. The acidification of the cytoplasm consequent upon activation of KefB (or KefC) is sufficient to give a high level of protection of the bacterial cell against electrophiles [16] . GSH maintains KefB and KefC in a closed state. Mutants lacking GSH exhibit a slow K + leak, via the KefB and KefC systems, that can be blocked by the GSH analogue ophthalmic acid [25] . Since ophthalmic acid does not carry a thiol group, the channels incubated with this peptide cannot be activated. Full activation of KefB and KefC is only observed upon formation of a glutathione adduct.
KefB was originally found to be a minor activity in E. coli cells. This is true when N-ethylmaleimide is the electrophile used to activate the systems, in which case KefB represents only ∼20% of the activity. However, this system is responsible for the majority of the MG-dependent activation of K + efflux [3, 16] . Moreover, the low rates of K + efflux originally observed have subsequently been revealed to reflect the influence of the relative activities of GlxI and GlxII. In E. coli K-12 the balance of the two activities favours GlxII, with the consequence that the pool of SLG is maintained at a relatively low level. When GlxI is overexpressed, the rate of MG detoxification increases only 3-fold, despite an increase of >30-fold in the activity of the enzyme. Since GlxII activity does not increase under these conditions, the metabolic limitation on detoxification is shifted from GlxI to GlxII. In the presence of increased GlxI activity, KefB exhibits much higher rates of K + efflux. The converse is also true. Overexpression of GlxII does not affect the rate of detoxification, but inhibits activation of KefB. These data are consistent with the size of the SLG pool being the major limiting factor on KefB activity [5] . However, increasing the expression of KefB also increases the rate of K + efflux upon addition of MG and causes significantly greater acidification of the cytoplasm. This increased acidification is sufficient to enhance the threshold concentration of MG tolerated by cells. Support for the significance of this mechanism for bacteria in their natural niche is provided by the increased expression of GlxI and KefB in pathogenic bacteria, which are changes in gene expression that potentiate protection.
Why is KefC poorly activated by MG? The answer to this question is not known. Recent data suggest that SLG binds to the protein but that the change in conformation is insufficient to cause the channel to open. Thus KefC is activated weakly by SLG, and this is evident from the observation that MGelicited K + efflux is only seen when KefC is overexpressed 30-fold [5] . Recently we have determined that mutations in KefC that alter the gating of the channel, such that cells expressing these mutant proteins leak K + , also dramatically increase the sensitivity to activation by MG. Three regulatory regions are known in KefC: the HALESDIE loop in the membrane domain, the Ktn domain and the SM domain ( [23] ; S. Miller, C. Li, B. Gunasekera, S. Kinghorn and I.R. Booth, unpublished work). Mutations in any of these three regions are sufficient to permit activation by MG. Further, other more subtle mutations that do not precipitate K + leak also lead to increased activation by MG. These data suggest that the energy barrier to channel opening in KefC is poised at a higher level than in KefB, such that binding of SLG is only rarely sufficient to gate the channel. Mutations that lower the activation energy for gating simultaneously increase the ability of SLG to gate the channel.
The ability of cells to tolerate MG is an intriguing adaptation mechanism. Production of MG creates a small window of opportunity for adaptation to either phosphate insufficiency or carbon super-sufficiency. To cope with this, a wide range of bacteria have evolved (or acquired) the Glx system plus other MG-detoxifying enzymes, and have developed the rather complex KefB channel to regulate cytoplasmic pH while detoxification takes place. The integration of the Glx system with activation of KefB means that the cell has a 'detoxification meter' -the GlxI enzyme generates the activator of KefB and removes its inhibitor, and the GlxII enzyme removes the activator and regenerates the inhibitor. Thus the pH of the cell during exposure to MG accurately reflects the balance of exposure to MG and the rate of detoxification. Protection is assured unless the cell fails to adapt!
